ArticleACS nanoscience Au2026
Binder-Free Direct Ink Writing of a Concentrated Dispersion of One-Dimensional Lepidocrocite Titanate Nanofilaments.
Article in ACS nanoscience Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct ink writing (DIW) of nanomaterial dispersions enables the production of structures and devices that combine the benefits of the nanomaterial properties with use-specific manufacturing designs. However, printing nanomaterial inks requires the ability to produce stable dispersions at concentrations high enough to meet the rheological criteria for DIW. Herein, we report on DIW of one-dimensional lepidocrocite (1DL) nanofilament, NF, dispersions at concentrations of 150 g/L, which are much greater than previously achieved concentrations. Moreover, the resulting birefringent, binder-free nematic gel can be printed into standard test patterns with outstanding dimensional accuracy, structural integrity, and shape fidelity. Both the ability to directly produce higher concentrations and the ability to print them open new opportunities for the production of functional 1DL materials and devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.